Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Clearpoint Neuro stock price, quote, forecast and news

CLPT
US18507C1036
A2PZ3E

Price

7.16
Today +/-
+0
Today %
+0 %
P

Clearpoint Neuro Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Clearpoint Neuro, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Clearpoint Neuro from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Clearpoint Neuro’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Clearpoint Neuro. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Clearpoint Neuro’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Clearpoint Neuro’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Clearpoint Neuro’s growth potential.

Clearpoint Neuro Revenue, EBIT and net profit per share

DateClearpoint Neuro RevenueClearpoint Neuro EBITClearpoint Neuro Net Income
2026e58.96 M undefined-19.18 M undefined-18.18 M undefined
2025e39.38 M undefined-19.33 M undefined-18.55 M undefined
2024e31.13 M undefined-19.93 M undefined-19.81 M undefined
202323.96 M undefined-22.45 M undefined-22.09 M undefined
202220.55 M undefined-16.33 M undefined-16.44 M undefined
202116.3 M undefined-13.37 M undefined-14.41 M undefined
202012.83 M undefined-6.22 M undefined-6.78 M undefined
201911.22 M undefined-4.59 M undefined-5.54 M undefined
20187.35 M undefined-5.25 M undefined-6.16 M undefined
20177.38 M undefined-6.34 M undefined-7.17 M undefined
20165.75 M undefined-7.49 M undefined-8.07 M undefined
20154.59 M undefined-7.72 M undefined-8.45 M undefined
20143.6 M undefined-9.66 M undefined-4.52 M undefined
20133.93 M undefined-7.47 M undefined-7.09 M undefined
20125.06 M undefined-4.01 M undefined-5.88 M undefined
20113.82 M undefined-5.92 M undefined-8.31 M undefined
20102.67 M undefined-9.52 M undefined-9.45 M undefined
20092.6 M undefined-7.06 M undefined-7.16 M undefined
20081.95 M undefined-5.23 M undefined-5.43 M undefined
20070 undefined-3.51 M undefined-3.7 M undefined
20060 undefined-1.14 M undefined-800,000 undefined
2005300,000 undefined-920,000 undefined-950,000 undefined

Clearpoint Neuro Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
000122353345771112162023313958
----100.00-50.0066.67-40.00-33.3325.0040.00-57.149.0933.3325.0015.0034.7825.8148.72
---100.00100.00100.00100.0080.0066.6733.3350.0060.0057.1457.1463.6475.0068.7565.0056.52---
0001223421234479111313000
0-1-3-5-7-9-5-4-7-9-7-7-6-5-4-6-13-16-22-19-19-19
----500.00-350.00-450.00-166.67-80.00-233.33-300.00-175.00-140.00-85.71-71.43-36.36-50.00-81.25-80.00-95.65-61.29-48.72-32.76
00-3-5-7-9-8-5-7-4-8-8-7-6-5-6-14-16-22-19-18-18
---66.6740.0028.57-11.11-37.5040.00-42.86100.00--12.50-14.29-16.6720.00133.3314.2937.50-13.64-5.26-
0.120.120.130.130.130.170.41.011.431.481.882.757.7410.9313.1615.8520.7324.1824.61000
----------------------
Details

Keystats

ⓘ

Revenue and Growth

The Clearpoint Neuro Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Clearpoint Neuro is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Clearpoint Neuro provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Clearpoint Neuro's financial health and stability.

Assets

Clearpoint Neuro's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Clearpoint Neuro must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Clearpoint Neuro after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Clearpoint Neuro's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20072008200920102011201220132014201520162017201820192020202120222023
-3-5-7-9-8-5-7-4-8-8-7-6-5-6-14-16-22
00000000000000000
00000000000000000
012-200-6-21-10-100-2-1-40
0001362-32233225814
00000000000001,000000
00000000000000000
-27-9-7-6-7-7-7-8-5-5-4-2-7-12-16-13
000000000000000-1-1
000000000000000-108
000000000000000-910
00000000000000000
00304303000-2-2-1000
00000599431107244700
0026499134311-15224600
00060000000000000
00000000000000000
-26-70-1115-3-25-621434-26-4
-3.056.31-9.76-7.77-6.27-7.56-7.95-7.3-8.72-5.92-6.02-4.69-3.01-8.29-12.87-17.32-14.77
00000000000000000

Clearpoint Neuro stock margins

The Clearpoint Neuro margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Clearpoint Neuro. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Clearpoint Neuro.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Clearpoint Neuro's sales revenue. A higher gross margin percentage indicates that the Clearpoint Neuro retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Clearpoint Neuro's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Clearpoint Neuro's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Clearpoint Neuro's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Clearpoint Neuro. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Clearpoint Neuro's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Clearpoint Neuro Margin History

Clearpoint Neuro Gross marginClearpoint Neuro Profit marginClearpoint Neuro EBIT marginClearpoint Neuro Profit margin
2026e56.83 %-32.53 %-30.84 %
2025e56.83 %-49.1 %-47.11 %
2024e56.83 %-64.02 %-63.64 %
202356.83 %-93.7 %-92.21 %
202265.84 %-79.46 %-80 %
202169.26 %-82.02 %-88.4 %
202071.08 %-48.48 %-52.84 %
201965.78 %-40.91 %-49.38 %
201866.94 %-71.43 %-83.81 %
201760.7 %-85.91 %-97.15 %
201654.09 %-130.26 %-140.35 %
201556.86 %-168.19 %-184.1 %
201446.67 %-268.33 %-125.56 %
201363.87 %-190.08 %-180.41 %
201288.93 %-79.25 %-116.21 %
201182.72 %-154.97 %-217.54 %
201099.25 %-356.55 %-353.93 %
2009100 %-271.54 %-275.38 %
2008100 %-268.21 %-278.46 %
200756.83 %0 %0 %
200656.83 %0 %0 %
200556.83 %-306.67 %-316.67 %

Clearpoint Neuro Stock Sales Revenue, EBIT, Earnings per Share

The Clearpoint Neuro earnings per share therefore indicates how much revenue Clearpoint Neuro has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Clearpoint Neuro earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Clearpoint Neuro's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Clearpoint Neuro’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Clearpoint Neuro's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Clearpoint Neuro Revenue, EBIT and net profit per share

DateClearpoint Neuro Sales per ShareClearpoint Neuro EBIT per shareClearpoint Neuro Earnings per Share
2026e2.15 undefined0 undefined-0.66 undefined
2025e1.44 undefined0 undefined-0.68 undefined
2024e1.14 undefined0 undefined-0.72 undefined
20230.97 undefined-0.91 undefined-0.9 undefined
20220.85 undefined-0.68 undefined-0.68 undefined
20210.79 undefined-0.64 undefined-0.7 undefined
20200.81 undefined-0.39 undefined-0.43 undefined
20190.85 undefined-0.35 undefined-0.42 undefined
20180.67 undefined-0.48 undefined-0.56 undefined
20170.95 undefined-0.82 undefined-0.93 undefined
20162.09 undefined-2.72 undefined-2.93 undefined
20152.44 undefined-4.11 undefined-4.49 undefined
20142.43 undefined-6.53 undefined-3.05 undefined
20132.75 undefined-5.22 undefined-4.96 undefined
20125.01 undefined-3.97 undefined-5.82 undefined
20119.55 undefined-14.8 undefined-20.78 undefined
201015.71 undefined-56 undefined-55.59 undefined
200920 undefined-54.31 undefined-55.08 undefined
200815 undefined-40.23 undefined-41.77 undefined
20070 undefined-27 undefined-28.46 undefined
20060 undefined-9.5 undefined-6.67 undefined
20052.5 undefined-7.67 undefined-7.92 undefined

Clearpoint Neuro business model

Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and marketing of advanced medical products and systems. The company was founded in 1998 and is headquartered in Irvine, California. Clearpoint Neuro's primary goal is to provide better care and treatment for patients with neurological disorders. Clearpoint Neuro was originally founded in 1998 under the name MRI Intervention to meet the market demand for innovative navigation systems for minimally invasive brain procedures. The company's initial products included imaging devices used during surgery. Since then, the company has expanded its product portfolio and strengthened its market position by focusing on core tasks in the field of medical technology. In 2011, MRI Intervention rebranded as Clearpoint Neuro to accommodate its growing product portfolio. The company now primarily focuses on the development and marketing of platform technologies for the control of minimally invasive instruments during neurosurgical procedures. Its customers include hospitals and research institutions that specialize in neurological and neuroscience applications. Clearpoint Neuro has built an extremely successful business model that specializes in providing advanced medical technology to benefit patients. The company works closely with leading neurosurgeons and researchers to understand the needs of patients and develop the most advanced technologies aimed at improving patient treatment. Clearpoint Neuro is a B2B (Business to Business) company that sells its products and services to hospitals and research institutions to ensure that its products are used by medical professionals with appropriate education and experience. The company also has a strong presence in the academic world, where it focuses on collaborating with laboratories and universities to advance the latest developments in technology and research. The divisions of Clearpoint Neuro include medical product areas developed from its technology base, which are described in more detail in the following sections. ClearPoint System ClearPoint is an intraoperative MRI system that is available as a core component of neurosurgical intervention platforms. It uses advanced technology for real-time localization and navigation of instruments to perform minimally invasive brain surgeries. It utilizes imaging technologies to enable navigation and coordination during the surgical procedure. ClearPoint Neuro Therapies ClearPoint Neuro Therapies includes three main areas: "DBS," "MRI-Guided Focused Ultrasound," and "Laser Therapy." DBS (Deep Brain Stimulation) is a minimally invasive neural therapy that involves the insertion of thin electrodes into the brain using a specially existing surgical technique to treat degenerative diseases, particularly Parkinson's disease. Another highly innovative therapy option is MRI-Guided Focused Ultrasound therapy, which targets and precisely destroys cancer cells using focused ultrasound waves. ClearPoint Neuro is one of the leading providers of this advanced therapy. Laser therapy involves the destruction of selected neural cells using heat. ClearPoint Neuro Navigation ClearPoint Neuro's navigation technologies are leading in neurosurgery and research. Navigation allows for precise placement of needles in the brain to obtain biopsies under ultrasound guidance or to administer medication targetedly without damaging the brain. The system is used by neurosurgeons and researchers worldwide. In conclusion, Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and manufacturing of advanced systems and products for neurosurgery and research. The company has built a strong business model by working closely with leading neurosurgeons and researchers and developing the most advanced technologies aimed at improving the quality of patient care. The ClearPoint System, ClearPoint Neuro Therapies, and ClearPoint Neuro Navigation divisions play a significant role in its success. Clearpoint Neuro is one of the most popular companies on Eulerpool.com.

Clearpoint Neuro SWOT Analysis

Strengths

Clearpoint Neuro Inc. has several strengths that contribute to its competitive advantage in the market:

  • Advanced technology and innovative products
  • Strong intellectual property portfolio
  • Experienced and skilled workforce
  • Established brand reputation and customer loyalty
  • Strong partnerships and collaborations

Weaknesses

Despite its strengths, Clearpoint Neuro Inc. also faces certain weaknesses that may hinder its growth:

  • Limited market presence compared to competitors
  • Dependence on key customers or partners
  • High production costs
  • Relatively small scale of operations
  • Limited financial resources

Opportunities

Clearpoint Neuro Inc. can capitalize on the following opportunities to enhance its market position:

  • Growing demand for neurological devices and treatments
  • Expansion into emerging markets
  • Increasing research and development in the neuroscience field
  • Strategic alliances and acquisitions to expand product portfolio
  • Advancements in healthcare technology

Threats

Clearpoint Neuro Inc. should be aware of the following threats that may impact its business:

  • Intense competition from established companies
  • Regulatory and compliance challenges in the healthcare industry
  • Economic downturns affecting healthcare spending
  • Rapid technological advancements making current products obsolete
  • Vulnerability to cybersecurity risks

Clearpoint Neuro historical P/E ratio, EBIT, and P/S ratio.

Clearpoint Neuro shares outstanding

The number of shares was Clearpoint Neuro in 2023 — This indicates how many shares 24.605 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Clearpoint Neuro earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Clearpoint Neuro's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Clearpoint Neuro’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Clearpoint Neuro's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Clearpoint Neuro Stock splits

In Clearpoint Neuro's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Clearpoint Neuro.

Clearpoint Neuro latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/2024-0.19 -0.16  (17.44 %)2024 Q1
12/31/2023-0.21 -0.19  (8.39 %)2023 Q4
9/30/2023-0.26 -0.2  (21.57 %)2023 Q3
6/30/2023-0.19 -0.29  (-49.64 %)2023 Q2
3/31/2023-0.19 -0.23  (-21.89 %)2023 Q1
12/31/2022-0.2 -0.18  (11.76 %)2022 Q4
9/30/2022-0.19 -0.15  (22.6 %)2022 Q3
6/30/2022-0.19 -0.18  (3.33 %)2022 Q2
3/31/2022-0.2 -0.17  (16.67 %)2022 Q1
12/31/2021-0.19 -0.2  (-3.2 %)2021 Q4
1
2
3
4

Clearpoint Neuro list of shareholders

%
Name
Stocks
Change
Date
4.97 % BlackRock Institutional Trust Company, N.A.1,361,587106,19412/31/2023
4.77 % The Vanguard Group, Inc.1,308,69433,41412/31/2023
3.26 % PTC Therapeutics Inc894,578-400,0006/13/2023
3.17 % Bigger Capital Funds, LP868,042121,04812/31/2023
1.78 % Geode Capital Management, L.L.C.489,15535,15612/31/2023
1.55 % Taylor Frigon Capital Management LLC424,09771,4913/31/2024
1.48 % District 2 Capital LP406,214238,86012/31/2023
1.31 % Bigger (Michael)358,69259,37612/31/2023
1.27 % State Street Global Advisors (US)348,89821,68412/31/2023
1.22 % Brown Advisory333,395012/31/2023
1
2
3
4
5
...
10

Clearpoint Neuro Executives and Management Board

Mr. Joseph Burnett46
Clearpoint Neuro President, Chief Executive Officer, Director (since 2017)
Compensation 2.13 M
Mr. Danilo D' Alessandro38
Clearpoint Neuro Chief Financial Officer
Compensation 918,373
Mr. Jeremy Stigall40
Clearpoint Neuro Executive Vice President, General Manager of Biologics & Drug Delivery
Compensation 751,736
Mr. R. John Fletcher77
Clearpoint Neuro Independent Chairman of the Board
Compensation 228,837
Mr. Pascal Girin63
Clearpoint Neuro Independent Director
Compensation 196,664
1
2
3

Clearpoint Neuro Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Siemens Healthineers Stock
Siemens Healthineers
SupplierCustomer0,450,620,630,750,010,30
Clinical Laserthermia Systems B Stock
Clinical Laserthermia Systems B
SupplierCustomer0,020,170,750,640,33-0,53
Koninklijke Philips Stock
Koninklijke Philips
SupplierCustomer0,01-0,210,400,490,920,41
Voyager Therapeutics Stock
Voyager Therapeutics
SupplierCustomer-0,170,190,59-0,11-0,41-0,59
1

Most common questions regarding Clearpoint Neuro

What values and corporate philosophy does Clearpoint Neuro represent?

Clearpoint Neuro Inc represents values of innovation, patient-focused care, and collaboration in the field of neurosurgery and neuromodulation. The company strives to improve patient outcomes by developing advanced technologies and solutions tailored to meet the unique needs of neurosurgeons. Clearpoint Neuro is dedicated to providing precision-guided therapies and enabling targeted delivery of therapies to the brain. Their corporate philosophy emphasizes the importance of cutting-edge research, strategic partnerships, and continuous improvement to drive advancements in neurological treatments. With a commitment to excellence, Clearpoint Neuro aims to make a significant impact in the lives of patients suffering from neurological disorders.

In which countries and regions is Clearpoint Neuro primarily present?

Clearpoint Neuro Inc is primarily present in the United States.

What significant milestones has the company Clearpoint Neuro achieved?

Clearpoint Neuro Inc has achieved several significant milestones. The company established itself as a leader in the field of neurosurgery by developing and commercializing a unique and innovative MRI-guided neurosurgical system called Clearpoint. This system allows precise and real-time guidance for brain surgeries, enhancing patient outcomes and reducing risks. In addition, Clearpoint Neuro Inc has successfully obtained regulatory clearances for its products in multiple countries, expanding its global reach. The company has also formed strategic partnerships with renowned medical institutions and received recognition for its advancements in neurosurgery. Clearpoint Neuro Inc continues to make advancements in the field, solidifying its position as a trusted provider of innovative neurosurgical solutions.

What is the history and background of the company Clearpoint Neuro?

Clearpoint Neuro Inc is a medical technology company specializing in the development and commercialization of devices for neurological procedures. Founded in 1999, Clearpoint Neuro has established itself as a leader in the field of image-guided neurosurgery. The company's innovative platform combines real-time MRI technology with surgical planning software, enabling precise targeting and accurate delivery of therapies to the brain. Clearpoint Neuro's devices have been utilized in various clinical applications, including the treatment of movement disorders, brain tumors, and epilepsy. With its commitment to advancing neurosurgical interventions, Clearpoint Neuro continues to push the boundaries of neuroscience to improve patient outcomes.

Who are the main competitors of Clearpoint Neuro in the market?

The main competitors of Clearpoint Neuro Inc in the market include companies such as Medtronic, Inc., Stryker Corporation, and Brainlab AG.

In which industries is Clearpoint Neuro primarily active?

Clearpoint Neuro Inc is primarily active in the medical device industry.

What is the business model of Clearpoint Neuro?

Clearpoint Neuro Inc's business model focuses on developing and commercializing innovative medical devices for a variety of neurosurgical procedures. The company primarily specializes in providing advanced technology solutions for neurologists and neurosurgeons, empowering them to precisely deliver therapeutic interventions to the brain. Clearpoint Neuro Inc's flagship product, the ClearPoint Neuro Navigation System, enables real-time MRI-guided neurosurgery, enhancing accuracy and patient outcomes. By combining imaging technology with surgical instruments, the company aims to revolutionize neurosurgical procedures. Clearpoint Neuro Inc's business model revolves around providing cutting-edge solutions that improve the precision, safety, and efficacy of neurosurgical interventions, ultimately benefiting patients and healthcare professionals alike.

What is the P/E ratio of Clearpoint Neuro 2024?

The Clearpoint Neuro P/E ratio is -8.89.

What is the P/S ratio of Clearpoint Neuro 2024?

The Clearpoint Neuro P/S ratio is 5.66.

What is the AlleAktien quality score of Clearpoint Neuro?

The AlleAktien quality score for Clearpoint Neuro is 7/10.

What is the revenue of Clearpoint Neuro 2024?

The expected Clearpoint Neuro revenue is 31.13 M USD.

How high is the profit of Clearpoint Neuro 2024?

The expected Clearpoint Neuro profit is -19.81 M USD.

What is the business model of Clearpoint Neuro

Clearpoint Neuro Inc. is an innovative company in the field of medical devices and imaging technologies. The company is headquartered in Irvine, California and operates worldwide. Clearpoint Neuro offers a wide range of solutions for the assessment of brain and central nervous system diseases. Clearpoint Neuro's business model is based on several divisions. On one hand, the company specializes in the development of imaging technologies and surgical instruments for the placement of electrodes and catheters in the brain. This includes the Clearpoint Neuro Navigation System and the SmartFrame®. The Clearpoint Neuro Navigation System allows neurosurgeons to combine electrophysiological and imaging data in real-time during surgical procedures. With the support of this system, neurosurgeons can determine the position of electrodes and catheters more precisely to perform targeted therapies for patients with Parkinson's, epilepsy, and other neurological diseases. The SmartFrame® is an instrument for the placement of catheters and probes in the brain and spine. It provides an extremely precise and reliable method for positioning drug pumps and other instruments for the treatment of pain as well as neurological or psychiatric disorders. In addition, Clearpoint Neuro also offers services such as training medical professionals in the effective use of navigation technology and surgical instruments. A third division of the company is the Clearpoint Neuro Customer Service team. This team provides comprehensive support to customers for any questions related to products and services. It is available for all inquiries and offers training, technical support, and other services. Another important area is the sale of consumables such as catheters and electrodes for electrophysiology. The company has a wide range of high-performance catheters specifically designed for use with the Clearpoint Neuro Navigation System. Clearpoint Neuro also has strategic partnerships with leading medical institutions and research facilities worldwide. These partnerships contribute to the advancement and improvement of Clearpoint Neuro products and provide a platform for future innovations and technologies. In summary, Clearpoint Neuro offers a broad portfolio of products and services for the assessment and treatment of neurological and central nervous system diseases. The company is committed to meeting the needs and requirements of its customers by providing innovative technologies and collaborating closely with its growing customer base.

What is the Clearpoint Neuro dividend?

Clearpoint Neuro pays a dividend of 0 USD distributed over payouts per year.

How often does Clearpoint Neuro pay dividends?

The dividend cannot currently be calculated for Clearpoint Neuro or the company does not pay out a dividend.

What is the Clearpoint Neuro ISIN?

The ISIN of Clearpoint Neuro is US18507C1036.

What is the Clearpoint Neuro WKN?

The WKN of Clearpoint Neuro is A2PZ3E.

What is the Clearpoint Neuro ticker?

The ticker of Clearpoint Neuro is CLPT.

How much dividend does Clearpoint Neuro pay?

Over the past 12 months, Clearpoint Neuro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clearpoint Neuro is expected to pay a dividend of 0 USD.

What is the dividend yield of Clearpoint Neuro?

The current dividend yield of Clearpoint Neuro is .

When does Clearpoint Neuro pay dividends?

Clearpoint Neuro pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Clearpoint Neuro?

Clearpoint Neuro paid dividends every year for the past 0 years.

What is the dividend of Clearpoint Neuro?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Clearpoint Neuro located?

Clearpoint Neuro is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clearpoint Neuro kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clearpoint Neuro from 8/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2024.

When did Clearpoint Neuro pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Clearpoint Neuro in the year 2023?

In the year 2023, Clearpoint Neuro distributed 0 USD as dividends.

In which currency does Clearpoint Neuro pay out the dividend?

The dividends of Clearpoint Neuro are distributed in USD.

All fundamentals about Clearpoint Neuro

Our stock analysis for Clearpoint Neuro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearpoint Neuro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.